La solution de Remedee Labs, reposant sur le premier bracelet stimulateur d’endorphines à base d’ondes millimétriques, devient le premier dispositif médical validé cliniquement et certifié en Europe pour soulager les symptômes de la fibromyalgie, une maladie pour laquelle aucun traitement spécifique n’avait encore été indiqué jusqu’à présent. Remedee Labs lancera sur le marché en 2025 son offre médicale dédiée aux personnes atteintes de fibromyalgie.

Brain signals reflect the handled activities and controlling behavior of the brain or the influence of the received information from other body parts either sensing or internal organs. Brain Computer Interfacing provides a channeling facility between brain and external equipment.

Gene sequence could be implanted with electrodes to make neurons larger and easier to ‘read’ in quest for better mind control of devices

The first implanted brain-computer interface has been turned on in the US. It allows a person to control a computer using only their thoughts. Though the tech is clunky, it could one day be used by astronauts and military personnel.

Humans controlling machines with their minds may sound like something from a sci-fi movie, but it’s becoming a reality through brain-computer interfaces. Understanding this emerging technology now can help ensure that effective policies are in place before BCI becomes a part of everyday life.

The findings, reported Sept. 1 at the European Society of Cardiology meeting and published in the Journal of the American College of Cardiology, provide inconclusive data about whether atrial fibrillation screening lowers stroke rates. The COVID pandemic led to an early halt of the study before fully enrolling, so it did not have enough participants to establish definitive results about stroke.

The controversial company said its second human patient is using the device to design 3D objects and play video games, while issues with the first patient’s device have been fixed.

Alex’s implant marks the second time Neuralink has successfully implanted its BCI into a patient. Earlier this year, Neuralink implanted it into Noland Arbaugh, a quadriplegic. According to the company, he controlled a computer cursor and played video games with the BCI. However, soon after receiving the implant, several threads from the BCI retracted from Mr. Arbaugh’s brain, significantly reducing the device’s capabilities. While the issue has been rectified, the malfunction raised concerns about the safety of Neuralink’s technology.

The company behind this, Inner Cosmos, calls their BCI a “Digital Pill for the Mind”; about the size of a penny, this wearable delivers precise micro-stimulations, similar to TMS, but without the need to visit a hospital for weeks in a row, or interact with the traditional machinery in the hospital setting. That is a game-changer in terms of the time, effort and cost of providing care or accessing treatment.

In a tissue culture model of the blood–brain barrier, antagonizing the interaction of CD200 and sCD200 with T-cell CD200 receptor (CD200R1) via anti-CD200 blocking antibodies or the RNAi-mediated inhibition of CD200 production by endothelial cells increased T-cell adhesion and transmigration across monolayers of endothelial cells. Our findings demonstrate that sCD200 produced by brain endothelial cells regulates immune cell trafficking through the blood–brain barrier and is primarily responsible for preventing activated T-cells from entering the brain.

Brain-computer interfaces are a groundbreaking technology that can help paralyzed people regain functions they’ve lost, like moving a hand. These devices record signals from the brain and decipher the user’s intended action, bypassing damaged or degraded nerves that would normally transmit those brain signals to control muscles.

The newly unlocked accessibility hasn't been wasted by Arbaugh as the Neuralink patient explained in a recent X post that he has been working with Neuralink from Monday to Friday for four hours each day, and that this work consists of mapping different body parts to various inputs such as left, right and middle click, improving the user-interface, practising handwriting by imagining letters being drawn, and other routine tasks that improve the technology.

Alex’s use of Neuralink’s brain chip allows him to game and design 3D models with ease.

With a focus on surgical and clinical translation strategies, this worldwide symposium will be the first-of-its-kind in setting the standard for BCI translation, implementation, and commercialization. The event will be hosted by a mix of leading startups (including Synchron and Precision Neuroscience) clinical institutional partners (including Mount Sinai, UPMC, CMU), federal regulatory organizations, and patient advocacy leaders. Keynotes, panels, and breakout sessions will be led by the world’s leading scientific, surgical, industry, and regulatory experts.

ChatGPT, intégré à la plateforme logicielle de l’ordinateur, joue un rôle d’assistant. Il propose des réponses contextuelles aux messages reçus, simplifiant ainsi l’interaction pour les utilisateurs. Cette fonctionnalité rappelle les suggestions automatiques de Gmail. Pour Mark, cette technologie a été une véritable bouée de sauvetage. Bien que ChatGPT ne nécessite aucun changement matériel sur l’implant, les mises à jour logicielles permettent d’intégrer différentes IA, rendant le système adaptable et évolutif.

L'implant cérébral de Synchron est désormais équipé de ChatGPT-4o, l'IA la plus évoluée d'OpenAI. Baptisé « Omni », cet outil analyse en temps réel texte, son et image. Cette innovation, de toute évidence, améliore la communication pour ceux avec des déficiences motrices. Avant, les utilisateurs devaient bouger un curseur sur un clavier virtuel. Mais maintenant, l'IA générative propose des réponses adaptées, ce qui rend les échanges plus naturels et fluides.

Carrying out any everyday task, be it driving in traffic, conversing with friends or playing basketball, requires rapid selection, integration and segregation of stimuli from different sensory modalities. At present, even the most advanced artificial intelligence-based systems are unable to replicate the multisensory processes that the human brain routinely performs, but how neural circuits in the brain carry out these processes is still not well understood. In this Perspective, we discuss recent findings that shed fresh light on the oscillatory neural mechanisms that mediate multisensory integration (MI), including power modulations, phase resetting, phase–amplitude coupling and dynamic functional connectivity.

Mark, a 64-year old man with amyotrophic lateral sclerosis (ALS), successfully used his direct thoughts to control the cursor on the Apple Vision Pro when he played Solitaire, watched Apple TV and sent text messages using the Synchron brain computer interface, hands-free. Mark is otherwise unable to use the Apple Vision Pro due to the loss of function of his upper limbs. Apple Vision Pro requires hand gestures to make item selections.

Researchers have discovered how glial cells can be reprogrammed into neurons through epigenetic modifications, offering hope for treating neurological disorders. This reprogramming involves complex molecular mechanisms, including the transcription factor Neurogenin2 and the newly identified protein YingYang1, which opens chromatin for reprogramming. The study reveals how coordinated epigenome changes drive this process, potentially leading to new therapies for brain injury and neurodegenerative diseases.

A new study reveals how brain inflammation from infections and neurodegenerative diseases causes muscle weakness by releasing the IL-6 protein. Researchers found that IL-6 travels from the brain to muscles, reducing their energy production and function. This discovery could lead to treatments for muscle wasting in diseases like Alzheimer’s and long COVID. Blocking the IL-6 pathway may prevent muscle weakness associated with brain inflammation.